Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.PH)

ZIOP.PH on Philadelphia Stock Exchange

4.32USD
20 Apr 2018
Change (% chg)

$0.01 (+0.35%)
Prev Close
$4.30
Open
$4.33
Day's High
$4.36
Day's Low
$4.27
Volume
6,635
Avg. Vol
9,782
52-wk High
$7.87
52-wk Low
$3.34

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.73
Market Cap(Mil.): $613.74
Shares Outstanding(Mil.): 142.40
Dividend: --
Yield (%): --

Financials

  ZIOP.PH Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -0.54 -- --
ROI: -61.98 -0.74 13.19
ROE: -- -2.80 15.00

BRIEF-Ziopharm Oncology Addresses Rumors And Stock Volatility, Affirms 2018 Guidance

* ZIOPHARM ONCOLOGY ADDRESSES RUMORS AND STOCK VOLATILITY, AFFIRMS 2018 GUIDANCE

Feb 06 2018

BRIEF-Ziopharm Oncology To Initiate Pivotal Trial Of Cancer Treatment in Second Half of 2018

* ZIOPHARM ONCOLOGY PROVIDES UPDATE ON STANDOUT TECHNOLOGIES DURING THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Jan 09 2018

BRIEF-Ziopharm Oncology reports third quarter financial results

* Ziopharm Oncology reports third quarter 2017 financial results and provides update on recent activities

Nov 06 2017

Earnings vs. Estimates